Holen Sie sich die Stockscreener-App
14.48
3.44%
-0.5699
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
About Us | Oil & Gas JournalVor Biopharma Inc.Common Stock (Nasdaq:VOR) Stock Quote - FinancialContent
Guidance Update: Can Vor Biopharma Inc keep up with sector leadersTrade Exit Report & Reliable Breakout Forecasts - baoquankhu1.vn
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Up 24.5% in February - MarketBeat
VOR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
VOR: Telitacicept advances in late-stage trials for MG and Sjögren's, targeting major autoimmune markets - TradingView
VOR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference - GlobeNewswire
Vor Bio schedules March 2 TD Cowen talk, investor meetings, webcast - Stock Titan
Pharma News: What are the analyst revisions for Vor Biopharma IncIs DMAC stock a good investment in YEARJuly 2025 Update & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Vor Biopharma Inc (VOR) Stock Price, Quote, News & History - Benzinga
[SCHEDULE 13G/A] Vor Biopharma Inc. Amended Passive Investment Disclosure - Stock Titan
Vor Bio Names Khan as Chief Medical Affairs Officer - Intellectia AI
Vor Bio Announces Inducement Grants in Compliance with Nasdaq Listing Rule 5635(c)(4) - Intellectia AI
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
VOR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VOR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Vor Biopharma (NASDAQ:VOR) Stock Price Down 4%What's Next? - MarketBeat
Vor Biopharma Shares Skyrocket on Global Licensing Deal for Autoimmune Therapy - MSN
Exit Recap: Can Vor Biopharma Inc. keep up with sector leadersJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
VOR Stock Unaffected by Selling Stockholders' Actions - GuruFocus
Is Vor Biopharma Inc. gaining market shareDollar Strength & Real-Time Stock Price Movement Reports - mfd.ru
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Aug EndMonth: What is the PEG ratio of Vor Biopharma IncGap Down & High Conviction Trade Alerts - baoquankhu1.vn
Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare ConferenceSlideshow - Seeking Alpha
VOR: TD Cowen Initiates Coverage with a 'Buy' Rating | VOR Stock News - GuruFocus
VOR: Telitacicept drives a global autoimmune strategy, backed by strong data, funding, and expert leadership - TradingView — Track All Markets
Quarterly Risk: How Vor Biopharma Inc stock valuations compare to rivals2025 Retail Activity & Weekly Top Performers Watchlists - Bộ Nội Vụ
Citigroup Initiates Coverage of Vor Biopharma (VOR) with Buy Recommendation - Nasdaq
Vor Biopharma (VOR) Receives New 'Buy' Rating From Citigroup | V - GuruFocus
Citigroup Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat
Citi Starts Vor Biopharma, Inc. (VOR) at Buy - StreetInsider
How Vor Biopharma Inc. stock responds to policy changes2025 EndofYear Setup & Growth Focused Investment Plans - ulpravda.ru
Will Vor Biopharma Inc. stock return to pre crisis levelsMarket Sentiment Report & Community Consensus Picks - ulpravda.ru
How Vor Biopharma Inc. stock valuations compare to rivals2025 Year in Review & High Accuracy Swing Entry Alerts - Улправда
Why Vor Biopharma Inc. stock remains a top recommendationTrade Volume Report & Stock Timing and Entry Methods - ulpravda.ru
Guidance Update: How Vor Biopharma Inc. stock responds to policy changes2025 Geopolitical Influence & AI Forecasted Stock Moves - Улправда
Why Vor Biopharma Inc. stock is a must watch in 2025Market Rally & Stepwise Entry and Exit Trade Signals - ulpravda.ru
How Vor Biopharma Inc. stock benefits from global expansionMonthly Performance Summary & Start Small. End Wealthy. - bollywoodhelpline.com
Vor Biopharma raises $42 million for cell therapy in leukemia | Biotechnology | The Pharmaletter - The Pharma Letter
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Autoimmune biotech Vor Bio to present at J.P. Morgan health conference - Stock Titan
What drives Vor Biopharma Inc stock priceInstitutional Buying Trends & Low Entry Cost Trading - earlytimes.in
Ariose Capital Management Ltd Invests $5.37 Million in Vor Biopharma Inc. $VOR - MarketBeat
Vor Biopharma Inc Stock Analysis and ForecastSell Signals and Alerts & Free High Yield Growth Strategies - earlytimes.in
Aug Macro: Will Vor Biopharma Inc stock outperform international peersFed Meeting & Verified Momentum Stock Watchlist - moha.gov.vn
Vor Biopharma CDO Departs, Transition Support Planned - TipRanks
Vor Biopharma Target of Unusually High Options Trading (NASDAQ:VOR) - MarketBeat
Portfolio Update: How Vor Biopharma Inc. stock benefits from global expansionTrade Risk Report & Fast Entry and Exit Trade Plans - moha.gov.vn
Vor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors - ts2.tech
Gap Down: Is Vor Biopharma Inc stock positioned well for digital economyJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - moha.gov.vn
Vor Biopharma (VOR) Stock Analysis Report | Financials & Insights - Benzinga
Vor Biopharma Inc. (NASDAQ:VOR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Moving Averages: How strong is Celsius Holdings Inc stock balance sheet2025 Short Interest & Community Verified Swing Trade Signals - moha.gov.vn
Vor Biopharma Stock (+7.4%): New Board Signals Institutional Backing - Trefis
Vor Biopharma Inc. (NASDAQ:VOR) Sees Large Growth in Short Interest - MarketBeat
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):